Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia
A 71-year-old woman complained of nausea and anorexia. Laboratory tests revealed significant neutrophilia and immunoglobulin A-kappa type M proteinemia, as well as increased plasma cells on bone marrow examination. Furthermore, the serum granulocyte-colony stimulating factor (G-CSF) concentration was high at 160 pg/ml, and the colony stimulating factor 3 receptor (CSF3R)-T618I mutation was negative. Immunohistochemical (IHC) analysis of bone marrow specimens using the anti-G-CSF antibody revealed immunopositivity of some myeloma cells. The patient was diagnosed using G-CSF-producing myeloma and was treated with daratumumab, lenalidomide, and dexamethasone. Her treatment resulted in a very good partial response, with normalization of both serum G-CSF levels and neutrophil count. There have been a few cases of G-CSF -producing myeloma reported, and it has previously been reported as chronic neutrophilic leukemia with M proteinemia. According to previous reports, techniques such as serum G-CSF measurements, IHC with an anti-G-CSF antibody, and CSF3R gene mutation analysis are useful for differentiating G-CSF-producing myeloma. However, the clinical characteristics and long-term prognosis of G-CSF-producing myeloma remain unknown. Additional case gathering and investigations are required.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
---|---|
Enthalten in: |
Rinsho ketsueki] The Japanese journal of clinical hematology - 64(2023), 8 vom: 05., Seite 735-740 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Yokoi, Momoko [VerfasserIn] |
---|
Links: |
---|
Themen: |
143011-72-7 |
---|
Anmerkungen: |
Date Completed 08.09.2023 Date Revised 08.09.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.11406/rinketsu.64.735 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361712707 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361712707 | ||
003 | DE-627 | ||
005 | 20231226085724.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||jpn c | ||
024 | 7 | |a 10.11406/rinketsu.64.735 |2 doi | |
028 | 5 | 2 | |a pubmed24n1205.xml |
035 | |a (DE-627)NLM361712707 | ||
035 | |a (NLM)37673624 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Yokoi, Momoko |e verfasserin |4 aut | |
245 | 1 | 0 | |a Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2023 | ||
500 | |a Date Revised 08.09.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A 71-year-old woman complained of nausea and anorexia. Laboratory tests revealed significant neutrophilia and immunoglobulin A-kappa type M proteinemia, as well as increased plasma cells on bone marrow examination. Furthermore, the serum granulocyte-colony stimulating factor (G-CSF) concentration was high at 160 pg/ml, and the colony stimulating factor 3 receptor (CSF3R)-T618I mutation was negative. Immunohistochemical (IHC) analysis of bone marrow specimens using the anti-G-CSF antibody revealed immunopositivity of some myeloma cells. The patient was diagnosed using G-CSF-producing myeloma and was treated with daratumumab, lenalidomide, and dexamethasone. Her treatment resulted in a very good partial response, with normalization of both serum G-CSF levels and neutrophil count. There have been a few cases of G-CSF -producing myeloma reported, and it has previously been reported as chronic neutrophilic leukemia with M proteinemia. According to previous reports, techniques such as serum G-CSF measurements, IHC with an anti-G-CSF antibody, and CSF3R gene mutation analysis are useful for differentiating G-CSF-producing myeloma. However, the clinical characteristics and long-term prognosis of G-CSF-producing myeloma remain unknown. Additional case gathering and investigations are required | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Granulocyte-colony stimulating factor | |
650 | 4 | |a Myeloma | |
650 | 4 | |a Neutrophilia | |
650 | 7 | |a Granulocyte Colony-Stimulating Factor |2 NLM | |
650 | 7 | |a 143011-72-7 |2 NLM | |
650 | 7 | |a Lenalidomide |2 NLM | |
650 | 7 | |a F0P408N6V4 |2 NLM | |
700 | 1 | |a Kondo, Toshinori |e verfasserin |4 aut | |
700 | 1 | |a Shimizu, Risa |e verfasserin |4 aut | |
700 | 1 | |a Uchida, Keiichi |e verfasserin |4 aut | |
700 | 1 | |a Hayashi, Shigeki |e verfasserin |4 aut | |
700 | 1 | |a Nishimura, Hirotake |e verfasserin |4 aut | |
700 | 1 | |a Kondo, Eisei |e verfasserin |4 aut | |
700 | 1 | |a Wada, Hideho |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rinsho ketsueki] The Japanese journal of clinical hematology |d 1972 |g 64(2023), 8 vom: 05., Seite 735-740 |w (DE-627)NLM000222178 |x 0485-1439 |7 nnns |
773 | 1 | 8 | |g volume:64 |g year:2023 |g number:8 |g day:05 |g pages:735-740 |
856 | 4 | 0 | |u http://dx.doi.org/10.11406/rinketsu.64.735 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 64 |j 2023 |e 8 |b 05 |h 735-740 |